Tatva Chintan Pharma Chem Ltd IPO (Tatva Chintan Pharma IPO) Detail

Jul 16, 2021 - Jul 20, 2021

Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.

The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.

Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.

Competitive strengths

  • Leading manufacturer of structure directing agents and phase transfer catalyst.
  • Diversified product portfolio.
  • Global market presence with customer base across industries.
  • Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
  • Experienced promoters and managers team.
  • Strong financial performance track record.

Company Promoters:

Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani are the company promoters.

Company Financials:

Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 3,148.03 2,489.38 1,875.08
Total Revenue 3,062.92 2,646.22 2,068.01
Profit After Tax 522.62 377.89 205.43

Objects of the Issue:

  • Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
  • Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
  • To meet general corporate purposes.

Tatva Chintan Pharma IPO Details

IPO Opening DateJul 16, 2021
IPO Closing DateJul 20, 2021
Issue TypeBook Built Issue IPO
Face Value₹10 per equity share
IPO Price₹1073 to ₹1083 per equity share
Market Lot13 Shares
Min Order Quantity13 Shares
Listing AtBSE, NSE
Issue Size[.] Eq Shares of ₹10
(aggregating up to ₹500.00 Cr)
Fresh Issue[.] Eq Shares of ₹10
(aggregating up to ₹225.00 Cr)
Offer for Sale[.] Eq Shares of ₹10
(aggregating up to ₹275.00 Cr)

Tatva Chintan Pharma IPO Tentative Timetable

The Tatva Chintan Pharma IPO open date is Jul 16, 2021, and the close date is Jul 20, 2021. The issue may list on Jul 29, 2021.

IPO Open DateJul 16, 2021
IPO Close DateJul 20, 2021
Basis of Allotment DateJul 26, 2021
Initiation of RefundsJul 27, 2021
Credit of Shares to Demat AccountJul 28, 2021
IPO Listing DateJul 29, 2021

Tatva Chintan Pharma IPO Lot Size

The Tatva Chintan Pharma IPO market lot size is 13 shares. A retail-individual investor can apply for up to 14 lots (182 shares or ₹197,106).

ApplicationLotsSharesAmount (Cut-off)
Minimum113₹14,079
Maximum14182₹197,106

Tatva Chintan Pharma IPO Promoter Holding

Pre Issue Share Holding100%
Post Issue Share Holding79.17%

Tatva Chintan Pharma IPO Subscription Status (Bidding Detail)

The Tatva Chintan Pharma IPO is subscribed 180.36x times on Jul 20, 2021 17:01. The public issue subscribed 35.35x in the retail category, 185.23x in the QIB category, and 512.22x in the NII category. Check Day by Day Subscription Details (Live Status)

CategoryIPO Subscription
QIB

185.23x

NII

512.22x

RII

35.35x

Total

180.36x

Note: Tatva Chintan Pharma IPO application wise subscription: 26 times

Tatva Chintan Pharma IPO Prospectus

Tatva Chintan Pharma IPO Rating

2646
4.2
Rating:Rated 4.2 stars

Vote Here ...

Tatva Chintan Pharma IPO Listing Date

Listing DateThursday, July 29, 2021
BSE Script Code543321
NSE SymbolTATVA
Listing InB Group of Securities
ISININE0GK401011
IPO Price₹1083 per equity share
Face Value₹10 per equity share

Listing Day Trading Information

.
IPO Price
Open
Low
High
Last Trade
Volume
BSE
₹1,083.00
₹2,111.80
₹2,111.80
₹2,486.30
₹2,310.25
898,537
NSE
₹1,083.00
₹2,111.85
₹2,111.85
₹2,534.20
₹2,312.20
7,860,870

Company Contact Information

Tatva Chintan Pharma Chem Ltd
Plot No. 502 / 17, GIDC Estate, Ankleshwar,
Bharuch, Gujarat - 393002, India


Phone: +91 75730 46951
Email: cs@tatvachintan.com
Website: http://www.tatvachintan.com/

Tatva Chintan Pharma IPO Registrar

Link Intime India Private Ltd
   Link Intime India Private Ltd
   C 101, 247 Park, L.B.S.Marg,
   Vikhroli (West), Mumbai - 400083

Phone: +91-22-4918 6270
Email: tatva.ipo@linkintime.co.in
Website: http://www.linkintime.co.in

Tatva Chintan Pharma IPO FAQs

  1. What is Tatva Chintan Pharma IPO?

    Tatva Chintan Pharma IPO is a main-board IPO of [.] equity shares of the face value of ₹10 aggregating up to ₹500.00 Crores. The issue is priced at ₹1073 to ₹1083 per equity share. The minimum order quantity is 13 Shares.

    The IPO opens on Jul 16, 2021, and closes on Jul 20, 2021.

    Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

  2. How to apply in Tatva Chintan Pharma IPO through Zerodha?

    Zerodha customers can apply online in Tatva Chintan Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Tatva Chintan Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.

    Steps to apply in Tatva Chintan Pharma IPO through Zerodha

    1. Visit the Zerodha website and login to Console.
    2. Go to Portfolio and click the IPOs link.
    3. Go to the 'Tatva Chintan Pharma IPO' row and click the 'Bid' button.
    4. Enter your UPI ID, Quantity, and Price.
    5. ‘Submit’ IPO application form.
    6. Visit the UPI App (net banking or BHIM) to approve the mandate.

    Visit Zerodha IPO Application Process Review for more detail.

  3. When Tatva Chintan Pharma IPO will open?

    The Tatva Chintan Pharma IPO opens on Jul 16, 2021 and closes on Jul 20, 2021.

  4. What is the lot size of Tatva Chintan Pharma IPO?

    Tatva Chintan Pharma IPO lot size is 13 Shares and the minimum order quantity is 13 Shares.

  5. How to apply for Tatva Chintan Pharma IPO?

    You can apply in Tatva Chintan Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

  6. When Tatva Chintan Pharma IPO allotment?

    The finalization of Basis of Allotment for Tatva Chintan Pharma IPO will be done on Jul 26, 2021, and the allotted shares will be credited to your demat account by Jul 28, 2021. Check the Tatva Chintan Pharma IPO allotment status.

  7. When is Tatva Chintan Pharma IPO listing date?

    The Tatva Chintan Pharma IPO listing date is on Thursday, July 29, 2021.

Tatva Chintan Pharma IPO Message Board

Ranked Members  Ranked Members

Loading...







Search Chittorgarh.com:

Download Our Mobile App

Android App iOS App